Tenaya Therapeutics, Inc.
TNYA
$0.88
$0.033.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.72M | 24.71M | 25.50M | 26.96M | 29.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.33M | 97.21M | 102.98M | 109.72M | 115.95M |
| Operating Income | -93.33M | -97.21M | -102.98M | -109.72M | -115.95M |
| Income Before Tax | -90.60M | -94.26M | -99.62M | -105.77M | -111.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -90.60 | -94.26 | -99.62 | -105.77 | -111.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -90.60M | -94.26M | -99.62M | -105.77M | -111.13M |
| EBIT | -93.33M | -97.21M | -102.98M | -109.72M | -115.95M |
| EBITDA | -84.90M | -88.51M | -94.05M | -100.75M | -107.48M |
| EPS Basic | -0.63 | -0.79 | -0.96 | -1.16 | -1.31 |
| Normalized Basic EPS | -0.39 | -0.49 | -0.60 | -0.73 | -0.82 |
| EPS Diluted | -0.63 | -0.79 | -0.96 | -1.16 | -1.31 |
| Normalized Diluted EPS | -0.39 | -0.49 | -0.60 | -0.73 | -0.82 |
| Average Basic Shares Outstanding | 611.05M | 522.41M | 445.23M | 368.14M | 339.26M |
| Average Diluted Shares Outstanding | 611.05M | 522.41M | 445.23M | 368.14M | 339.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |